MiR-124-3p helps to protect against acute respiratory distress syndrome by targeting p65

Yufeng Liang1, Junjie Xie2, Di Che3

  • 1Pediatric Intensive Care Unit, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong province, China.

Bioscience Reports
|May 12, 2020
PubMed
Abstract

Insights

MicroRNA-124-3p (miR-124-3p) suppresses inflammation in acute respiratory distress syndrome (ARDS). This study shows miR-124-3p targets p65, reducing lung injury and apoptosis in an ARDS mouse model.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Immunology

Background:

  • Acute respiratory distress syndrome (ARDS) is a severe lung injury with high mortality.
  • MicroRNA-124-3p (miR-124-3p) is known to suppress inflammation but its role in ARDS is unclear.
  • The precise mechanism of miR-124-3p in pulmonary injury requires elucidation.

Purpose of the Study:

  • To investigate the role and mechanism of miR-124-3p in lipopolysaccharide (LPS)-induced ARDS.
  • To determine if miR-124-3p can mitigate lung injury and inflammation in an ARDS model.
  • To explore the interaction between miR-124-3p and the p65 signaling pathway.

Main Methods:

  • Induced ARDS in mice and NR8383 cells using LPS.
  • Administered miR-124-3p agomir to mice and evaluated pulmonary injury and inflammatory cytokines.
  • Confirmed the direct interaction between miR-124-3p and p65 using luciferase assays and assessed effects on apoptosis.

Main Results:

  • LPS exposure decreased miR-124-3p levels in lung tissues and cells.
  • miR-124-3p agomir treatment significantly reduced lung injury and levels of IL-1β, IL-6, and TNF-α.
  • Overexpression of miR-124-3p suppressed LPS-induced p65 expression and cell apoptosis in vitro and in vivo.

Conclusions:

  • miR-124-3p directly targets p65 in the context of ARDS.
  • miR-124-3p exerts protective effects by reducing inflammation and pulmonary injury.
  • This finding highlights miR-124-3p as a potential therapeutic target for ARDS.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
656
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
906
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
369
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
695
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
450